USD91.29 ₽ EUR98.07 ₽ telegram Telegram
2024-04-16 обновлены отчеты компании WINT: 20232022
Windtree Therapeutics logo
Windtree Therapeutics WINT
$ 4.79 8.83%

Windtree Therapeutics Мультипликаторы 2011-2024 | WINT

Мультипликаторы по годам Windtree Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.1 -0.0 -2.7 -5.0 -0.9 -0.2 -0.3 -0.3 -8.1 -8.4 -7.0 -7.0

P/S

- - - - 695.4 10.8 3.1 5.4 16.8 125.2 973.5 1305.4 253.7

EPS

-5.2 -62.2 -136.6 -2.1 -2.5 -7.7 -24.1 -4.7 -8.0 -7.3 -0.8 -0.9 -0.9

EV (Enterprise Value)

26.4 млн 24.9 млн 11.1 млн 114 млн 159 млн 59.5 млн 30 млн 43.9 млн 14 млн 338 млн 324 млн 246 млн 149 млн

EBITDA per Share

-5.29 -64.8 -156 -2.06 -2.42 -12.9 -48.2 -272 -438 -140 -219 -262 -291

EV/EBITDA

-0.5 -2.3 -5.1 -1.6 -1.1 -0.8 -0.1 -7.8 -7.1 -6.4 -5.9

PEG

-0.0 -0.0 -0.0 -0.16 -0.06 -0.01 -0.0 -0.01 0.0 -0.22 -0.55 4.12 -0.15

P/B

0.5 0.3 0.0 1.3 1.8 0.3 -0.2 -0.4 2.0 18.5 6.5 14.8 116.4

P/CF

-0.1 -0.2 -0.0 -3.4 -5.5 -1.2 -0.2 -0.3 -0.5 -8.5 -9.2 -7.8 -6.5

ROE %

-598.38 -391.61 -161.50 -46.82 -36.67 -30.15 77.12 136.98 -667.43 -229.48 -77.30 -211.41 -1659.02

ROA %

-62.61 -103.30 -90.44 -28.85 -23.09 -17.20 -551.12 -407.16 -124.32 -92.76 -50.64 -124.82 -157.67

ROCE %

-607.40 -412.83 -184.52 -28.40 -24.01 -19.78 198.79 1030.23 -154.89 -109.04 -57.51 -207.80 -1114.09

Current Ratio

1.1 1.4 2.3 3.0 3.1 1.2 0.2 0.5 3.7 5.8 7.3 2.4 1.0

DSO

- - - - - - - - - - 93.6 - -

DIO

- - - - - - - - - - 70.2 44.2 -

DPO

- - - - - - - - 145.0 - 982.7 265.5 -

Операционный цикл

- - - - - - - - - - 163.8 44.2 -

Финансовый цикл

- - - - - - - - -145.0 - -818.9 -221.2 -

Все данные представлены в валюте USD

Мультипликаторы поквартально Windtree Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.86 -1.64 -4.76 - -6.51 -29.68 -14.36 - -0.31 -1.42 -0.51 - -0.54 -0.63 -0.48 -0.21 -0.66 -0.6 -0.61 -3.24 -1.04 -0.81 -1.4 1.03 -10.53 -14.37 -27.4 -0.77 -1 -1.29 -1.7 -1.26 -2.8 -1.82 -1.96 -1.68 -1.82 -1.68 -1.96 -0.16 -0.22 -0.18 -0.29 -0.16 -0.31 -0.16 -0.37 -0.18 -0.2 -0.34 -0.21

EBITDA per Share

- - -4.83 - -6.65 -29.2 -13.9 - -0.3 -1.72 -0.51 - -0.52 -0.52 -0.49 -0.13 -0.65 -0.59 -0.62 -0.67 -0.89 -0.79 -1.49 -1.45 -6.58 -11.9 -17.9 -0.75 -0.9 -1.2 -1.69 -1.22 -1.04 -1.61 -1.76 -1.84 -1.6 -1.74 -1.75 -0.14 -0.19 -0.21 -0.28 -0.29 -0.21 -0.19 -0.23 -243 -216 -239 -317

ROE %

-197.78 -161.94 -195.34 -136.97 -153.34 -146.43 -122.00 -92.03 -105.00 -101.60 -49.47 -36.11 -45.95 -42.49 -37.34 -36.67 -40.10 -36.35 -32.24 -30.15 -27.21 1.31 34.02 77.12 110.35 116.61 125.23 136.98 -8.22 -298.01 -471.88 -667.43 -600.53 -398.73 -317.05 -229.48 -194.14 -156.05 -115.47 -77.29 -95.85 -150.55 -176.24 -211.38 -513.04 -813.31 -1411.80 -1658.62 -375.87 -638.92 -303.56

ROA %

-48.66 -44.82 -62.00 -54.00 -63.68 -64.93 -72.62 -57.42 -65.41 -63.72 -31.04 -22.25 -28.44 -26.44 -23.39 -23.09 -24.47 -21.77 -18.91 -17.20 64.26 -95.07 -294.25 -551.12 -693.08 -616.68 -524.48 -407.16 -361.87 -324.22 -240.20 -124.32 -123.93 -99.20 -96.04 -92.76 -83.50 -73.34 -60.64 -50.62 -60.25 -91.14 -105.32 -124.62 -134.14 -125.23 -162.00 -157.35 -35.66 -60.61 -28.80

ROCE %

-207.21 -171.24 -204.37 -142.05 -158.28 -147.82 -136.38 -106.07 -118.59 -114.87 -46.38 -33.58 -39.66 -36.73 -33.97 -33.22 -34.26 -29.76 -25.55 -23.78 -2.03 23.10 53.23 94.26 101.73 108.51 117.50 131.93 -8.48 -137.45 -298.37 -481.90 -422.05 -373.69 -304.42 -225.31 -184.39 -149.08 -110.57 -76.08 -128.92 -167.07 -198.53 -214.24 -610.86 -1042.36 -1497.16 -1939.24 -488.13 -504.75 -479.35

Current Ratio

1.3 1.4 1.2 1.4 1.6 1.6 2.1 2.3 2.5 2.7 3.1 2.6 2.6 2.6 2.6 2.7 2.7 2.7 2.7 2.3 2.3 2.3 2.3 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 1.2 1.2 1.2 1.2 1.7 1.7 1.7 1.7 2.9 2.9 2.9 2.9 2.4 2.4 2.4 2.4 1.1 1.1 1.1 1.1

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.8 5.5 1.7 98.6 - 101.9 33.6 42.5 - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.8 5.5 1.7 98.6 - 101.9 33.6 42.5 - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.8 5.5 1.7 98.6 - 101.9 33.6 42.5 - - - - - - - -

Все данные представлены в валюте USD